Delivery Order SPE2DB24D3013-SPE2DB25FFQZF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Metoprolol Succinate Extended Release 50 mg, valued at $1,312.12. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The products will be delivered to Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of 1,000 tablets of Metoprolol Succinate Extended Release 50 mg, with a contract ceiling value of $4,081.00 and completion deadline of September 11, 2025. This is a firm fixed-price delivery order issued without set-aside restrictions, meaning it was competitively awarded. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Metoprolol Succinate Extended Release 50 mg tablets (100-count bottles) with a ceiling value of $1,239.66. This firm fixed-price delivery order is scheduled for ultimate completion by September 29, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $1,615.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Metoprolol Succinate Extended Release 50 mg tablets in a quantity of 1,000 units. The contract is classified as a non-set-aside competitive award with an ultimate completion date of August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $5,194.72 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Metoprolol Succinate ER 50 mg, with an ultimate completion date of May 9, 2025. This competitively awarded, firm fixed-price contract was issued on May 8, 2025, with no set-aside designation, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Metoprolol Succinate Extended Release 50 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,190.86. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by June 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,155.00 to AmerisourceBergen Drug Corp for 1,000 tablets of Metoprolol Succinate Extended-Release 50 mg, with an ultimate completion date of July 28, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Metoprolol Succinate Extended Release 50 mg tablets (1,000 count) with a ceiling value of $1,698.57. This firm fixed price delivery order, awarded on August 12, 2025, represents a non-competitive set-aside procurement and is set to be completed by August 13, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug...
- This federal contract award is for the delivery of Metoprolol Succinate Extended-Release 25mg tablets in 1,000-count bottles to the Defense Logistics Agency (DLA). The $6,335.98 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 23, 2022 with a completion date of September 26, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,052.29 firm fixed price delivery order covers the supply of 4,558,966,079 units of the prescription medication Metoprolol Succinate Extended-Release 100 mg tablets. The award has an ultimate completion date of November 3, 2022 and was made on November 2, 2022. This delivery order is part of Amerisourcebergen's...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQZFDelivery Order
The Defense Logistics Agency awarded a $2,922.58 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of 1,000 tablets of Metoprolol Succinate ER 25 mg, with performance to be completed by September 26, 2025. The contract was awarded on a firm fixed-price basis without set-aside designation, reflecting open competition among qualified vendors. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. The company's established role as a critical pharmaceutical distributor for the Defense Health Agency and other government entities, combined with its demonstrated capability to fulfill federal procurement requirements, positions it as a key supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/25/25 |